| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/07/2001 | WO2001043747A8 Matrix tablet for prolonged release of trimetazidine after oral administration |
| 09/07/2001 | WO2001034115A3 Method for encapsulating proteins or peptides in liposomes, liposomes produced using said method, and their use |
| 09/07/2001 | WO2001022923A3 Scar treatment composition |
| 09/07/2001 | WO2001016289A3 Zymogen activation system |
| 09/07/2001 | WO2001016169A3 RET LIGAND 5 (Retl5) FROM HUMAN AND MOUSE |
| 09/07/2001 | WO2001014395A3 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 09/07/2001 | WO2001010408A3 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 09/07/2001 | WO2000076528A3 Pharmaceutical preparation containing proteins |
| 09/07/2001 | WO2000071571A3 Fap-activated anti-tumor compounds |
| 09/07/2001 | WO2000050004A3 Surgical anesthesia delivery system |
| 09/07/2001 | WO2000046384A9 Nucleic acid uptake and release vehicle |
| 09/07/2001 | CA2401869A1 Agent for the treatment of wounds |
| 09/07/2001 | CA2401804A1 Urogenital or anorectal transmucosal vaccine delivery system |
| 09/07/2001 | CA2401800A1 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 09/07/2001 | CA2401696A1 Therapeutic compositions for pulmonary delivery |
| 09/07/2001 | CA2401613A1 Amino acids sequencing facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/07/2001 | CA2401352A1 Immune enhancement compositions and use thereof |
| 09/07/2001 | CA2401340A1 Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors |
| 09/07/2001 | CA2401288A1 Improvements in or relating to the delivery of oral drugs |
| 09/07/2001 | CA2401022A1 Methods for treating fsh related conditions with gnrh antagonists |
| 09/07/2001 | CA2400950A1 Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 09/07/2001 | CA2400138A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 09/07/2001 | CA2374585A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/07/2001 | CA2372185A1 Novel pharmaceutical or dietetic mushroom-based compositions |
| 09/07/2001 | CA2370741A1 Method for detecting and killing epithelial cancer cells |
| 09/06/2001 | US20010020147 Delivery of oral drugs |
| 09/06/2001 | US20010020083 Sulfiding/nitrosylating cyclodextrins to form coating for medical devices (tubes, catheters) |
| 09/06/2001 | US20010020029 New multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H- indazole-3-carboxamide hydrochloride |
| 09/06/2001 | US20010020016 Formulation |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010020005 Administering a gastrin inhibitor |
| 09/06/2001 | US20010019841 Medium and matrix for long-term proliferation of cells |
| 09/06/2001 | US20010019819 Freeze drying platelets |
| 09/06/2001 | US20010019724 Carotenoid formulations, comprising a mixture of beta-carotene, lycopene and lutein |
| 09/06/2001 | US20010019721 Liquid composition |
| 09/06/2001 | US20010019719 Intravesical drug delivery system |
| 09/06/2001 | US20010019712 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response |
| 09/06/2001 | US20010018916 Process and device for inhalation of particulate medicaments |
| 09/06/2001 | DE19962251A1 Lozenge with thermally neutral dissolution properties containing active substance with exothermic dissolution behavior and compensatory adjuvant with endothermic dissolution behavior |
| 09/05/2001 | EP1130009A1 Generation and screening of a dynamic combinatorial library |
| 09/05/2001 | EP1129771A1 Microcapsules |
| 09/05/2001 | EP1129725A2 Oligonucleotide conjugates |
| 09/05/2001 | EP1129724A2 Vaccines for treating colon cancer |
| 09/05/2001 | EP1129723A1 Combined vaccine against both hav and measle virus and method of producing it |
| 09/05/2001 | EP1129720A2 Stabilized granulocyte colony stimulating factor |
| 09/05/2001 | EP1129713A1 Veterinary compositions for the treatment of parasitic diseases |
| 09/05/2001 | EP1129709A2 Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof |
| 09/05/2001 | EP1129209A2 Polymer grafting by polysaccharide synthases |
| 09/05/2001 | EP1129094A2 Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same |
| 09/05/2001 | EP1129064A1 Transfection reagents |
| 09/05/2001 | EP1129029A1 Silicon dioxide with mesopores and micropores |
| 09/05/2001 | EP1128848A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers |
| 09/05/2001 | EP1128847A1 Antibody-serum protein hybrids |
| 09/05/2001 | EP1128841A2 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 09/05/2001 | EP1128835A1 Cyanocobalamin (vitamin b 12?) treatment in allergic disease |
| 09/05/2001 | EP1128831A1 Pharmaceutical moxifloxacin preparation |
| 09/05/2001 | EP1128827A1 Pharmaceutical composition for modified release insulin sensitiser |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128824A1 Ionic silver complex |
| 09/05/2001 | EP1128821A1 A capsule based drug delivery system |
| 09/05/2001 | EP1128820A1 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 09/05/2001 | EP1128819A1 New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 09/05/2001 | EP1128816A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 09/05/2001 | EP1128815A1 Process for preparing oral calcium compositions |
| 09/05/2001 | EP1128813A1 An inhalation system |
| 09/05/2001 | EP1128810A1 Drug delivery device, especially for the delivery of androgens |
| 09/05/2001 | EP1128809A1 Aqueous ophthalmic formulations comprising chitosan |
| 09/05/2001 | EP1128800A1 Flavour blend for masking unpleasant taste of zinc compounds |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP0804162B1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 09/05/2001 | EP0760677B1 A pharmaceutical preparation comprising glucagon |
| 09/05/2001 | EP0746334B1 Pharmaceutical preparation containing plasminogen activators |
| 09/05/2001 | EP0744938B1 Liquid ophthalmic sustained release delivery system |
| 09/05/2001 | EP0681572B1 Thiazolidinethione-activated polyalkylene oxides |
| 09/05/2001 | CN1311798A Method for producing powder-shaped cross-linked polymerizates |
| 09/05/2001 | CN1311686A Pulmonary delivery of active agents |
| 09/05/2001 | CN1311672A Pharmaceutical composition for injection based on paracetamol |
| 09/05/2001 | CN1311669A Orally disintegrable tablet |
| 09/05/2001 | CN1311668A Two-piece capsule for receiving pharmaceutical prepns. for powder inhalers |
| 09/05/2001 | CN1311666A Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 09/05/2001 | CN1311010A Smoke inhaling article for medical use, and its mfg. method |
| 09/05/2001 | CN1070370C Crystalline amifostine compositions and process for prepn. of same and use thereof |
| 09/04/2001 | US6284884 Depolymerization and reacting with base to form de-n-acetylated polysaccharide; reacting with nitrosation agent |
| 09/04/2001 | US6284805 Aqueous solution of an acid addition salt of a 1-alkyl-n-(2,6-dimethylphenyl)-2-piperidinecaboxamide, wherein the solution is buffered. |
| 09/04/2001 | US6284804 Intended for application to the eye, ear or nose |
| 09/04/2001 | US6284797 Capsaicin; norepinephrine inhibitor and a vasodilator which act to promote blood circulation in the treatment area |
| 09/04/2001 | US6284792 Formulation of valnemulin |
| 09/04/2001 | US6284754 Penetration of membrane |
| 09/04/2001 | US6284749 Mixture of fungicide with chelate compound |
| 09/04/2001 | US6284747 Pharmaceutical formulation |
| 09/04/2001 | US6284746 Anticancer agents |
| 09/04/2001 | US6284745 Gel compositions |
| 09/04/2001 | US6284744 Mixture of drug and hyaluronic acid; abdomen surgery |
| 09/04/2001 | US6284738 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 09/04/2001 | US6284725 Administering binding compound for glucagon receptor such asglucagon-like peptide |
| 09/04/2001 | US6284305 Applying undercoat comprising polymeric material and biologically active material to stent portion; applying discontinuous topcoat which covers less than entire surface of undercoat, topcoat comprising nonporous polymeric material |
| 09/04/2001 | US6284283 Method of producing sub-micron particles of biologically active agents and uses thereof |
| 09/04/2001 | US6284277 Stable freeze-dried pharmaceutical formulation |
| 09/04/2001 | US6284276 Soluble form osmotic dose delivery system |
| 09/04/2001 | US6284273 Cross-linked high amylose starch resistant to amylase as a matrix for the slow release of biologically active compounds |